These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 12206823)
1. Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics. Faller C; Bracher M; Dami N; Roguet R Toxicol In Vitro; 2002 Oct; 16(5):557-72. PubMed ID: 12206823 [TBL] [Abstract][Full Text] [Related]
2. Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential. Perkins MA; Osborne R; Rana FR; Ghassemi A; Robinson MK Toxicol Sci; 1999 Apr; 48(2):218-29. PubMed ID: 10353313 [TBL] [Abstract][Full Text] [Related]
3. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test. Spielmann H; Hoffmann S; Liebsch M; Botham P; Fentem JH; Eskes C; Roguet R; Cotovio J; Cole T; Worth A; Heylings J; Jones P; Robles C; Kandárová H; Gamer A; Remmele M; Curren R; Raabe H; Cockshott A; Gerner I; Zuang V Altern Lab Anim; 2007 Dec; 35(6):559-601. PubMed ID: 18186667 [TBL] [Abstract][Full Text] [Related]
4. A catch-up validation study on reconstructed human epidermis (SkinEthic RHE) for full replacement of the Draize skin irritation test. Alépée N; Tornier C; Robert C; Amsellem C; Roux MH; Doucet O; Pachot J; Méloni M; de Brugerolle de Fraissinette A Toxicol In Vitro; 2010 Feb; 24(1):257-66. PubMed ID: 19733228 [TBL] [Abstract][Full Text] [Related]
5. An approach for development of alternative test methods based on mechanisms of skin irritation. Osborne R; Perkins MA Food Chem Toxicol; 1994 Feb; 32(2):133-42. PubMed ID: 8132172 [TBL] [Abstract][Full Text] [Related]
6. Analysis of interleukin-1alpha (IL-1alpha) and interleukin-8 (IL-8) expression and release in in vitro reconstructed human epidermis for the prediction of in vivo skin irritation and/or sensitization. Coquette A; Berna N; Vandenbosch A; Rosdy M; De Wever B; Poumay Y Toxicol In Vitro; 2003 Jun; 17(3):311-21. PubMed ID: 12781210 [TBL] [Abstract][Full Text] [Related]
7. In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols. Tornier C; Rosdy M; Maibach HI Toxicol In Vitro; 2006 Jun; 20(4):401-16. PubMed ID: 16229985 [TBL] [Abstract][Full Text] [Related]
8. In vitro skin irritation testing: Improving the sensitivity of the EpiDerm skin irritation test protocol. Kandárová H; Hayden P; Klausner M; Kubilus J; Kearney P; Sheasgreen J Altern Lab Anim; 2009 Dec; 37(6):671-89. PubMed ID: 20105002 [TBL] [Abstract][Full Text] [Related]
9. Development of an in vitro corrosion/irritation prediction assay using the EpiDerm skin model. Kidd DA; Johnson M; Clements J Toxicol In Vitro; 2007 Oct; 21(7):1292-7. PubMed ID: 17936572 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of skin irritation potentials of different cosmetic products in Turkish market by reconstructed human epidermis model. Kose O; Erkekoglu P; Sabuncuoglu S; Kocer-Gumusel B Regul Toxicol Pharmacol; 2018 Oct; 98():268-273. PubMed ID: 30138660 [TBL] [Abstract][Full Text] [Related]
11. Establishment and evaluation of immortalized human epidermal keratinocytes for an alternative skin irritation test. Kim CW; Kim CD; Choi KC J Pharmacol Toxicol Methods; 2017; 88(Pt 2):130-139. PubMed ID: 28827132 [TBL] [Abstract][Full Text] [Related]
12. A prevalidation study on in vitro tests for acute skin irritation. results and evaluation by the Management Team. Fentem JH; Briggs D; Chesné C; Elliott GR; Harbell JW; Heylings JR; Portes P; Roguet R; van de Sandt JJ; Botham PA Toxicol In Vitro; 2001 Feb; 15(1):57-93. PubMed ID: 11259870 [TBL] [Abstract][Full Text] [Related]
13. In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Welss T; Basketter DA; Schröder KR Toxicol In Vitro; 2004 Jun; 18(3):231-43. PubMed ID: 15046769 [TBL] [Abstract][Full Text] [Related]
14. Potential method to determine irritant potency in vitro - Comparison of two reconstructed epidermal culture models with different barrier competency. Spiekstra SW; Dos Santos GG; Scheper RJ; Gibbs S Toxicol In Vitro; 2009 Mar; 23(2):349-55. PubMed ID: 19135141 [TBL] [Abstract][Full Text] [Related]
16. Comparison of irritant potential of shampoos using cultured human epidermal keratinocytes model and patch test reaction measured by laser Doppler flowmetry. Eun HC; Jung SY Contact Dermatitis; 1994 Mar; 30(3):168-71. PubMed ID: 8187517 [TBL] [Abstract][Full Text] [Related]
17. The usefulness of toxicogenomics for predicting acute skin irritation on in vitro reconstructed human epidermis. Borlon C; Godard P; Eskes C; Hartung T; Zuang V; Toussaint O Toxicology; 2007 Nov; 241(3):157-66. PubMed ID: 17928126 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the optimized SkinEthic Reconstructed Human Epidermis (RHE) 42 bis skin irritation protocol over 39 test substances. Tornier C; Amsellem C; Fraissinette Ade B; Alépée N Toxicol In Vitro; 2010 Feb; 24(1):245-56. PubMed ID: 19733227 [TBL] [Abstract][Full Text] [Related]
19. SkinEthic™ RHE for in vitro evaluation of skin irritation of medical device extracts. Pellevoisin C; Videau C; Briotet D; Grégoire C; Tornier C; Alonso A; Rigaudeau AS; Bouez C; Seyler N Toxicol In Vitro; 2018 Aug; 50():418-425. PubMed ID: 29339149 [TBL] [Abstract][Full Text] [Related]
20. The in vitro skin irritation of chemicals: optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process. Cotovio J; Grandidier MH; Portes P; Roguet R; Rubinstenn G Altern Lab Anim; 2005 Aug; 33(4):329-49. PubMed ID: 16185103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]